Vimta Labs Ltd

NSE: VIMTALABS · BSE: 524394 · Healthcare · 35 announcements

Share price: ₹507.95
Market cap: ₹2,271 Cr
Revenue (annual): ₹407.3 Cr
Net profit (annual): ₹77.51 Cr
P/E (TTM): 28.3×Sector 54.5×
Promoter holding: 35.64%-0.03% QoQ
FII holding: 5.07%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Earnings Call 2 Results Update 1 Other Announcement 1 Merger & Restructuring 1 Financial Results 1 Board Meeting Date 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

30 Oct 2026 19:50 IST BSE

Merger & Restructuring

Vimta Labs Merger & Restructuring Worth ₹0.08 Cr

Vimta Labs incorporated wholly owned US subsidiary Vimta Labs LLC, investing about INR 0.08 Crore (USD 8,500). The contract research unit supports the parent's testing business.

Value: ₹0.08 Cr

Open announcement → Read the filing ↗